Anti-GD2 Therapeutic Antibody (Dinutuximab)
Recombinant chimeric (human/Mouse) antibody expressed in CHO binding to human GD2. Dinutuximab is a chimeric monoclonal antibody that induces antibody dependent cell-mediated cytotoxicity. Dinutuximab is intended as maintenance therapy (targeting minimal residual disease) for high risk neuroblastoma, administered after induction therapy, autologous stem cell transplantation and/or radiotherapy.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-731 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | GD2 |
| Species Reactivity | Human |
| Type | IgG1 - kappa |
| Applications | Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, ICC and most other immunological methods. |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |